Wiesendanger, M; Kneitz, B; Edelmann, W et al. (2000) Somatic hypermutation in MutS homologue (MSH)3-, MSH6-, and MSH3/MSH6-deficient mice reveals a role for the MSH2-MSH6 heterodimer in modulating the base substitution pattern. J Exp Med 191:579-84
|
Zuckier, L S; Berkowitz, E Z; Sattenberg, R J et al. (2000) Influence of affinity and antigen density on antibody localization in a modifiable tumor targeting model. Cancer Res 60:7008-13
|
Casadevall, A; Cleare, W; Feldmesser, M et al. (1998) Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrob Agents Chemother 42:1437-46
|
Yuan, R R; Spira, G; Oh, J et al. (1998) Isotype switching increases efficacy of antibody protection against Cryptococcus neoformans infection in mice. Infect Immun 66:1057-62
|
Green, N S; Lin, M M; Scharff, M D (1998) Immunoglobulin hypermutation in cultured cells. Immunol Rev 162:77-87
|
Valadon, P; Nussbaum, G; Oh, J et al. (1998) Aspects of antigen mimicry revealed by immunization with a peptide mimetic of Cryptococcus neoformans polysaccharide. J Immunol 161:1829-36
|
Yuan, R; Clynes, R; Oh, J et al. (1998) Antibody-mediated modulation of Cryptococcus neoformans infection is dependent on distinct Fc receptor functions and IgG subclasses. J Exp Med 187:641-8
|
Nussbaum, G; Cleare, W; Casadevall, A et al. (1997) Epitope location in the Cryptococcus neoformans capsule is a determinant of antibody efficacy. J Exp Med 185:685-94
|
Yuan, R R; Casadevall, A; Oh, J et al. (1997) T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice. Proc Natl Acad Sci U S A 94:2483-8
|
Lin, M M; Zhu, M; Scharff, M D (1997) Sequence dependent hypermutation of the immunoglobulin heavy chain in cultured B cells. Proc Natl Acad Sci U S A 94:5284-9
|
Showing the most recent 10 out of 46 publications